Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Amicus Therapeutics, Inc. (NQ: FOLD)
3.410 USD  -0.020 (-0.58%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 20, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Amicus Therapeutics, Inc.
 
< Previous 1 2 3 4 5 6 Next >
Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Rally Insmed
May 14, 2013
category Pharmaceuticals
from Trefis
Stocks Crossing 50-Day SMA 03/18: (AMD) (KORS) (FOLD) Above; (NXPI) (WFR) (MHR) Below
March 18, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8193120 for the full story. Read More
from StreetInsider.com News Articles
Biotech Movers: Spectrum, AEterna Among Big Losers
March 18, 2013
 Read More
category NASDAQ:FOLD , NASDAQ:XNPT , NASDAQ:CLVS , and 3 more.
from InvestorPlace - Latest Headlines
Amicus Therapeutics, Inc. (FOLD) Posts Q4 Loss of 20c/Share
March 12, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8178562 for the full story. Read More
from StreetInsider.com News Articles
Earnings Scheduled For March 12, 2013
March 12, 2013
Costco Wholesale (NASDAQ: COST ) is estimated to report its Q2 earnings at $1.06 per share on revenue of $25.13 billion. Bridgepoint Education (NYSE: BPI ) is projected to report its Q4 earnings at... Read More
category LMIA , Earnings , Benzinga , and 33 more.
from Latest Articles from Benzinga.com
Biotech Movers: Big Bumps All Around
February 19, 2013
 Read More
category NASDAQ:FOLD , NASDAQ:DSCO , NASDAQ:INCY , and 3 more.
from InvestorPlace - Latest Headlines
Amicus Reports Additional Trial Data
February 15, 2013
Amicus Therapeutics Inc. (Nasdaq: FOLD) reported additional interim results from an ongoing Phase 3 study of its Fabry disease treatment. The stock price plunged $1.00 to close at $2.89.... Read More
from MarketMinute.com Stock News
Stocks Crossing 50-Day SMA 02/15: (GPS) (MNST) (AMRN) Above; (WMT) (TGT) (FOLD) Below
February 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8106444 for the full story. Read More
from StreetInsider.com News Articles
Unusual 11 Mid-Day Movers 02/15: (URRE) (QLIK) (SAAS) Higher; (LOGM) (FOLD) (EHTH) Lower
February 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8106203 for the full story. Read More
from StreetInsider.com News Articles
Flat Markets Over Mixed Economic Data
February 15, 2013
The markets traded near the flatline during the midday during the midday with the Dow edging down 2 points to 13,966 as investors weighed rising consumer sentiment against an unexpected slip in... Read More
category Market News
from MarketMinute.com Market Updates
Stock to Watch: Amicus Therapeutics Down 20.3% (FOLD)
February 15, 2013
from Comtex SmarTrend® News Briefs
Amicus Therapeutics (FOLD) Ticks Lower on Following Study Results
February 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8105691 for the full story. Read More
from StreetInsider.com News Articles
Amicus Therapeutics Advances Chaperone-ERT Combo Platform in Pompe Diesease
February 14, 2013
Amicus Therapeutics (Nasdaq: FOLD ) today announced positive results from clinical and preclinical studies of the pharmacological chaperone AT2220 (duvoglustat HCl) in combination with ERT for Pompe... Read More
category Benzinga , News , FDA , and 1 more.
from Latest Articles from Benzinga.com
Biotech Catalyst Trades For This Week
January 28, 2013
category Pharmaceuticals
from Trefis
8 Biotechnology Stocks to Sell Now
January 16, 2013
 Read More
category NASDAQ:FOLD , NYSE:ELN , NASDAQ:ACHN , and 6 more.
from InvestorPlace - Latest Headlines
Amicus Offers FY13 Guidance, Update on Strategic Outlook
January 07, 2013
Amicus Therapeutics (Nasdaq: FOLD ), a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases, today provided its full-year 2013 strategic outlook and financial... Read More
category Benzinga , Guidance , US03152W1099 , and 2 more.
from Latest Articles from Benzinga.com
Amicus (FOLD) Sees Net Cash Spend Up to $58M in FY13; Provides Update
January 07, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7989103 for the full story. Read More
from StreetInsider.com News Articles
Csrnewsdaily.com Issues Investment Alert On (NASDAQ:FOLD), (NYSE:JNJ), (NYSE:LLY), (NASDAQ:ARAY), (NASDAQ:RPRX)
January 04, 2013
category FINANCING , Stock Market News
from Latest eTeligis Press Releases with 'Plus' ranking
Mid-Day Follow-Up Commentary On Selected picks: (NASDAQ: ARAY), (NASDAQ: FOLD)
January 04, 2013
category AGRICULTURE , NUTRITION , RELIGION , and 128 more.
from Latest eTeligis Press Releases with 'Plus' ranking
Unusual 11 Mid-Day Movers 01/04: (DRYS) (SCTY) (HNR) Higher; (ARAY) (SIMG) (FINL) Lower
January 04, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7986406 for the full story. Read More
from StreetInsider.com News Articles
Jobs Data Meets Expectations, Markets Open Flat
January 04, 2013
The markets opened flat with the Dow holding steady at 13,391 as employers added 155,000 jobs in December. Nasdaq slipped 5 points to 3094. On the upsideCredit Suisse upgraded Alcatel-Lucent (NYSE:... Read More
category Market News
from MarketMinute.com Market Updates
StreetInsider.com Pre-Open Movers 01/04: (FOLD) (HNR) (KKD) Higher; (ARAY) (FINL) (LULU) Lower (more...)
January 04, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7985825 for the full story. Read More
from StreetInsider.com News Articles
Friday’s biggest gaining and declining stocks
January 04, 2013
Amicus, Harvest Natural and Finish Line are all on the move, while metals ETFs are the talk of Twitter after Thursday’s Fed minutes prompted a big selloff in gold and silver. Read More
category GLD , Transportation Equipment , ARAY , and 14 more.
from MarketWatch
Amicus Announces Positive Phase 2 Results for Chaperone-Enzyme Replacement Therapy Co-Administration Study for Pompe Disease
January 04, 2013
Amicus Therapeutics (NASDAQ: FOLD ) today announced positive preliminary results from all 4 dose cohorts in a Phase 2 study (Study 010) to evaluate the safety and pharmacokinetic (PK) effects of the... Read More
category Management , Benzinga , Asset Sales , and 5 more.
from Latest Articles from Benzinga.com
Amicus Therapeutics (FOLD) Reports Positive Data from All Cohorts in ERT Co-Admin Study for Pompe Disease
January 04, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7985438 for the full story. Read More
from StreetInsider.com News Articles
Thursday's movers, Sonus Networks Inc. (NASDAQ:SONS) and Amicus Therapeutics, Inc.(NASDAQ:FOLD) Have Been Added to Growing Stock Report's Watch List.
January 03, 2013
from ACCESSWIRE
Unusual 11 Mid-Day Movers 01/03: (SPWR) (LDK) (BGMD) Higher; (LPH) (ALLT) (MLNX) Lower
January 03, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7981591 for the full story. Read More
from StreetInsider.com News Articles
Markets Flat Over Mixed Retail Sales
January 03, 2013
The markets traded near the flatline with the Dow adding 4 points to 13,417 on mixed December retail sales. Nasdaq rose 4 points to 3116. Read More
category Market News
from MarketMinute.com Market Updates
Janney Montgomery Scott Starts Amicus Therapeutics (FOLD) at Buy
January 02, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7978586 for the full story. Read More
from StreetInsider.com News Articles
A Triple Play Of Biotech Disappointments Last Week (ONTY, FOLD, HEB, GSK)
December 28, 2012
Investors got a triple-dose of bad biotech news this week. Read More
from Investopedia Advisor Commentary
< Previous 1 2 3 4 5 6 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here